Bullisch
$310.11
Szenariopreis
$313.030
+16.497 (+5.27%)Zum Schluss
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution.
Veeva Systems Inc is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $296.13, and the company has a forward P/E ratio of 30.21, indicating reasonable growth expectations. Additionally, the stock has shown a 34.92% year-to-date change, reflecting strong momentum. However, the RSI is at 77.75, suggesting it may be overbought, which is a risk to consider.
Wells Fargo
$330
2026-09-08
Wells Fargo
2026-09-08
Kursziel
$330
Citi
$273
2026-08-28
Citi
2026-08-28
Kursziel
$273
Truist
$305
2026-08-27
Truist
2026-08-27
Kursziel
$305
Stifel
$300
2026-08-27
Stifel
2026-08-27
Kursziel
$300
RBC Capital
$325
2026-08-27
RBC Capital
2026-08-27
Kursziel
$325
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Paul Sekhri Appointed Chair of iOnctura Board

Veeva Systems to Host 2026 Investor Day Virtually

IQVIA and Veeva Expand Partnership with New Standard Applications

Investment Opportunities in High-Growth Stocks Amid Rising Yields

Veeva Summit Accelerates Drug Development Innovations
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).
Veeva Systems Inc is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $296.13, and the company has a forward P/E ratio of 30.21, indicating reasonable growth expectations. Additionally, the stock has shown a 34.92% year-to-date change, reflecting strong momentum. However, the RSI is at 77.75, suggesting it may be overbought, which is a risk to consider.
14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.